- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 192794, 6 pages
Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis
Department of Gastroenterology, Kitasato University School of Medicine, 2-1-1 Asamizodai, Minami, Sagamihara 252-0380, Japan
Received 11 February 2013; Accepted 27 February 2013
Academic Editor: Devendra Amre
Copyright © 2013 Kaoru Yokoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. Rutgeerts, W. J. Sandborn, B. G. Feagan et al., “Infliximab for induction and maintenance therapy for ulcerative colitis,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2462–2476, 2005.
- J. F. Colombel, W. J. Sandborn, W. Reinisch et al., “Infliximab, azathioprine, or combination therapy for Crohn's disease,” The New England Journal of Medicine, vol. 362, no. 15, pp. 1383–1395, 2010.
- P. Rutgeerts, G. Van Assche, W. J. Sandborn et al., “Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial,” Gastroenterology, vol. 142, no. 5, pp. 1102–1111, 2012.
- M. F. Neurath and S. P. Travis, “Mucosal healing in inflammatory bowel diseases: a systematic review,” Gut, vol. 61, no. 10, pp. 1619–1635, 2012.
- K. W. Schroeder, W. J. Tremaine, and D. M. Ilstrup, “Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study,” The New England Journal of Medicine, vol. 317, no. 26, pp. 1625–1629, 1987.
- S. Kane, D. Huo, J. Aikens, and S. Hanauer, “Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis,” American Journal of Medicine, vol. 114, no. 1, pp. 39–43, 2003.
- T. Kudo, T. Matsumoto, M. Esaki, T. Yao, and M. Iida, “Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation,” International Journal of Colorectal Disease, vol. 24, no. 5, pp. 495–501, 2009.
- M. Fujiya, Y. Saitoh, M. Nomura et al., “Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis.,” Gastrointestinal Endoscopy, vol. 56, no. 4, pp. 535–542, 2002.
- K. T. Thia, E. V. Loftus Jr., D. S. Pardi et al., “Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity,” Inflammatory Bowel Diseases, vol. 17, no. 6, pp. 1257–1264, 2011.
- G. Meucci, R. Fasoli, S. Saibeni et al., “Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study,” Inflammatory Bowel Diseases, vol. 18, no. 6, pp. 1006–1010, 2012.
- J. F. Colombel, P. Rutgeerts, W. Reinisch et al., “Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis,” Gastroenterology, vol. 141, no. 4, pp. 1194–1201, 2011.